FGF21 and obesity due to melanocortin 4 receptor deficiency: The administration of exogenous FGF21 in mice and primates improves obesity-related insulin resistance, glucose and lipid homeostasis, further suggesting a major role in the regulation of systemic metabolism (8–11).